Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 70 results for aneurysm

  1. Endovascular aneurysm sealing for abdominal aortic aneurysm (IPG547)

      March 2019: We have withdrawn the guidance because the CE mark for the Nellix Endovascular Aneurysm Sealing (EVAS) System has been withdrawn. Endologix is recalling unused stock. The MHRA recommends enhanced patient surveillance (see MDA/2019/002) because of a high risk of the graft failing beyond 2 years after implantation.

  2. Blood transfusion (QS138)

    This quality standard covers the general principles of blood transfusion in adults, young people and children over 1 year old. It describes high-quality care in priority areas for improvement. It does not cover specific conditions that blood transfusion is used for.

  3. Novel endovascular interventions: What is the clinical and cost effectiveness of novel endovascular techniques and devices such as coated coils, endoluminal flow diverters and intrasaccular devices to treat aneurysmal subarachnoid haemorrhage?

    recommendation for research, see the rationale section on managing the culprit aneurysm. Full details of the evidence and the...

  4. Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhage (IPG701)

    Evidence-based recommendations on inducing and maintaining normothermia using temperature modulation devices after stroke or subarachnoid haemorrhage in adults. This involves cooling the body using pads placed on the skin or tubes put into the body.

  5. What are the most effective and cost-effective frequencies for monitoring people with unruptured abdominal aortic aneurysms (AAA) of different diameters, and what is the optimal AAA threshold size (inner-to-inner maximum anterior-posterior diameter on ultrasound) for repair?

    applicable) More frequent monitoring increases the chances of identifying aneurysms that have grown large enough to be considered for...

  6. Pneumonia (community-acquired): antimicrobial prescribing (NG138)

    This guideline sets out an antimicrobial prescribing strategy for community-acquired pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.

  7. Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)

    Summary of the evidence on antimicrobial prescribing: delafloxacin

  8. Nimodipine: What is the clinical and cost effectiveness of nimodipine in the management of aneurysmal subarachnoid haemorrhage?

    Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued

  9. Predictors of death and disability: What variables predict death or disability for people with aneurysmal subarachnoid haemorrhage?

    Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued

  10. Risk stratification tool to estimate risk of recurrence: What is the utility of a risk stratification tool to estimate the risk of subsequent aneurysmal subarachnoid haemorrhage?

    Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued

  11. Managing acute hydrocephalus: What is the most clinically and cost-effective method of cerebrospinal fluid drainage or diversion (for example shunt surgery, external ventricular drain surgery or lumbar drain) for symptomatic acute hydrocephalus?

    Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued

  12. Vasopressors to manage delayed cerebral ischaemia: What is the clinical and cost effectiveness of vasopressors to manage delayed cerebral ischaemia in people with aneurysmal subarachnoid haemorrhage?

    Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued

  13. Intra-arterial therapies to manage delayed cerebral ischaemia: What is the impact of intra-arterial therapies to manage delayed cerebral ischaemia on outcome in people with aneurysmal subarachnoid haemorrhage?

    Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued

  14. Transcranial doppler monitoring: What is the clinical and cost effectiveness of routine transcranial doppler monitoring to guide clinical management of aneurysmal subarachnoid haemorrhage?

    Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued